C8G

C8G encodes the gamma chain of complement component C8, a lipocalin-family protein that forms a disulfide-linked heterodimer with C8A via Cys40–Cys164 and, together with C8B, assembles into the C8 heterotrimer required for membrane attack complex (MAC) formation (PMID:3676249, PMID:1707134). High-resolution crystal structures reveal a deep hydrophobic calyx characteristic of lipocalins, whose entrance is physically occluded by a C8A indel in the assembled alpha-gamma complex, indicating that ligand access is conformationally regulated during MAC assembly (PMID:12033936, PMID:18440555). Although C8G is dispensable for MAC-mediated erythrocyte lysis and bacterial killing, it enhances bactericidal efficiency (PMID:12413696). Independent of the complement system, C8G is expressed in perivascular astrocytes where it antagonizes sphingosine-1-phosphate receptor 2 (S1PR2), suppressing S1P-driven microglial neuroinflammation and preserving blood–brain barrier integrity (PMID:33382892, PMID:34149451).

1. 1987 High

   Establishing that C8G is the product of a distinct gene resolved how the three C8 subunits are independently synthesized and then assembled via covalent and noncovalent interactions in the liver.

   Evidence cDNA cloning and Northern blot of baboon and rat liver poly(A) RNA with subunit-specific probes

   PMID:3676249

   Open questions at the time

   • Mechanism of intracellular assembly of C8 trimer not defined
   • Signals directing C8G secretion not characterized
2. 1989 High

   Mapping C8G to chromosome 9q, separate from the linked C8A/C8B locus on 1p, demonstrated that alpha-gamma disulfide linkage occurs post-translationally from independently regulated loci.

   Evidence Somatic cell hybrid panel with subunit-specific cDNA probes and genomic restriction analysis

   PMID:2613233

   Open questions at the time

   • Regulatory consequences of separate chromosomal locations not explored
3. 1991 Medium

   Identifying C8G as a lipocalin family member and mapping the Cys40 disulfide to C8A Cys164 defined the structural basis for alpha-gamma dimer formation and raised the possibility of small hydrophobic ligand binding.

   Evidence Disulfide-bond mapping by peptide sequencing; retinol/retinoic acid binding assay; molecular modeling

   PMID:1707134

   Open questions at the time

   • Ligand binding required non-physiological 2 M NaCl, casting doubt on in vivo relevance
   • No crystal structure available at the time
   • Physiological ligand identity unresolved
4. 1994 High

   Characterization of the C8G gene structure (7 exons, ~1.8 kb) and identification of upstream SP1, glucocorticoid response elements, and SV40 enhancer core motifs provided a framework for understanding transcriptional regulation.

   Evidence Genomic cloning, S1 nuclease mapping, anchored PCR for transcription start site

   PMID:8172891

   Open questions at the time

   • Functional validation of putative regulatory elements not performed at this stage
5. 1995 Medium

   Demonstrating IL-6-mediated upregulation of C8G in HepG2 cells established C8 as a positive acute-phase reactant, linking complement MAC assembly to inflammatory signaling.

   Evidence Immunoprecipitation and SDS-PAGE of biosynthetically labeled subunits from IL-6-treated HepG2 cells

   PMID:7710765

   Open questions at the time

   • In vivo acute-phase regulation not confirmed
   • Mechanism of IL-6 transcriptional activation of C8G not dissected
6. 2002 High

   Reconstitution experiments showed that C8G is dispensable for MAC hemolytic and bactericidal activity but enhances bacterial killing, redefining C8G's role from essential structural subunit to modulatory enhancer of MAC function.

   Evidence Purified subunit reconstitution in erythrocyte lysis and bacterial killing assays

   PMID:12413696

   Open questions at the time

   • Molecular mechanism by which C8G enhances bactericidal activity not determined
   • Whether C8G modulates MAC pore stoichiometry or kinetics unknown
7. 2002 High

   The 1.2 Å crystal structure of free C8G revealed a deep hydrophobic calyx larger than NGAL's and a partially disordered loop 1 near the calyx entrance, providing the first atomic-resolution view of a potential ligand-binding site.

   Evidence X-ray crystallography of recombinant C8G at 1.2 Å resolution

   PMID:12033936

   Open questions at the time

   • No ligand co-crystal obtained
   • Physiological ligand identity still unknown
8. 2008 High

   The 2.15 Å co-crystal structure of C8A-MACPF with C8G showed that a 19-residue C8A indel occludes the C8G calyx entrance, explaining why ligand binding may be regulated by conformational changes during MAC assembly.

   Evidence X-ray crystallography of alphaMACPF-gamma complex at 2.15 Å resolution

   PMID:18440555

   Open questions at the time

   • Whether calyx opening occurs during MAC insertion into target membranes is untested
   • Identity of any physiological calyx ligand remains unknown
9. 2021 High

   Discovery that astrocyte-expressed C8G antagonizes S1PR2 to suppress microglial neuroinflammation and protect blood–brain barrier integrity established a complement-independent neuroimmune function for C8G.

   Evidence Recombinant C8G gain-of-function and shRNA loss-of-function in mouse neuroinflammation models; Co-IP identifying S1PR2 interaction; in vitro BBB permeability assays

   PMID:33382892 PMID:34149451

   Open questions at the time

   • Binding interface between C8G and S1PR2 not structurally resolved
   • Source of brain C8G (local astrocyte production vs. plasma-derived) not fully distinguished
   • Relevance to human neurological disease not demonstrated
10. 2024 High

    Identification of HNF4α as a direct transcriptional activator of hepatic C8G expression connected C8G regulation to a master hepatocyte transcription factor, explaining liver-predominant expression.

    Evidence Liver-specific Hnf4a-knockout mice; forced HNF4α expression in hepatocytes; transactivation assay with binding site mutations

    PMID:39285151

    Open questions at the time

    • Whether HNF4α also controls C8G expression in astrocytes unknown
    • Interplay with IL-6-mediated acute-phase regulation not integrated

• The physiological ligand of the C8G lipocalin calyx remains unidentified, and whether calyx ligand binding occurs in vivo—particularly during MAC pore assembly when the C8A indel might disengage—is the central unresolved mechanistic question.
• No endogenous ligand identified for the C8G calyx
• Structural dynamics of calyx opening during MAC assembly untested
• Contribution of C8G to MAC pore architecture at cryo-EM resolution not resolved